Compare PRLB & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRLB | BHC |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2011 | 1996 |
| Metric | PRLB | BHC |
|---|---|---|
| Price | $80.81 | $4.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $53.00 | $8.00 |
| AVG Volume (30 Days) | 251.8K | ★ 2.9M |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.33 | ★ 423.08 |
| EPS | ★ 0.33 | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $8.56 | $4.61 |
| Revenue Next Year | $6.89 | N/A |
| P/E Ratio | $233.67 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $38.48 | $4.57 |
| 52 Week High | $83.15 | $8.69 |
| Indicator | PRLB | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 61.12 | 37.28 |
| Support Level | $71.59 | N/A |
| Resistance Level | $82.76 | $6.31 |
| Average True Range (ATR) | 2.75 | 0.16 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 94.24 | 28.89 |
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.